Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Invesco Discovery Fund's investment thesis on Guardant Health, Inc. ($GH) — Q4 2025 | Buyside Digest

All Pitches

View Letter Analysis

$GHNYSEGuardant Health, Inc.

BULL

Invesco Discovery Fund—GH

Fund Letter

Q4 2025

Published December 31, 2025

View Fund Profile

$161.50USD

+0.1% vs last month

$101.74Pitched

+58.7% since pitch

Market Cap$21.4B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

The Invesco Discovery Fund outperformed its benchmark, the Russell 2000 Growth Index, in Q4 2025, driven primarily by strong stock selection in the information technology and industrials sectors. Portfolio managers Ronald...

— Ronald Zibelli, Asutosh Shah

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $GH, and what else Invesco Discovery Fund is buying.

Other pitches on $GH

Other investors who've written on Guardant Health, Inc.

Aristotle Core Equity FundBULL

Pitched Aug 10, 2026

Guardant Health contributed to performance in the second quarter following a string of positive developments, as several catalysts played out during the quarter. The...

View all $GH pitches →